Ricardo A Cruciani

Summary

Affiliation: Beth Israel Medical Center
Country: USA

Publications

  1. pmc False sense of safety by daily QTc interval monitoring during methadone IVPCA titration in a patient with chronic pain
    Hector Miranda-Grajales
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY, USA
    J Pain Res 6:375-8. 2013
  2. ncbi request reprint Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study
    Ricardo A Cruciani
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York 10003, USA
    J Pain Symptom Manage 32:551-9. 2006
  3. doi request reprint Methadone: to ECG or not to ECG...That is still the question
    Ricardo A Cruciani
    Research Division, Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York 10003, USA
    J Pain Symptom Manage 36:545-52. 2008
  4. doi request reprint L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled study
    Ricardo A Cruciani
    Research Division, Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    J Pain Symptom Manage 37:622-31. 2009
  5. doi request reprint MMTP patients with chronic pain switching to pain management clinics. A problem or an acceptable practice?
    Ricardo A Cruciani
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York 10003, USA
    Pain Med 9:359-64. 2008
  6. pmc Using Transcranial Direct Current Stimulation to Treat Depression in HIV-Infected Persons: The Outcomes of a Feasibility Study
    Helena Knotkova
    Research Division, Department of Pain Medicine and Palliative Care, Institute for Non invasive Brain Stimulation, Beth Israel Medical Center New York, NY, USA
    Front Psychiatry 3:59. 2012
  7. pmc L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial
    Ricardo A Cruciani
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    J Clin Oncol 30:3864-9. 2012
  8. doi request reprint Transcranial direct current stimulation (tDCS) relieved itching in a patient with chronic neuropathic pain
    Helena Knotkova
    Institute for Non invasive Brain Stimulation, Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY, USA
    Clin J Pain 29:621-2. 2013
  9. ncbi request reprint Measurement of QTc in patients receiving chronic methadone therapy
    Ricardo A Cruciani
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York 10003, USA
    J Pain Symptom Manage 29:385-91. 2005
  10. ncbi request reprint Potential impact of abrupt opioid therapy discontinuation in the management of chronic pain: a pilot study on patient perspective
    Joy Hao
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York Department of Medicine, Beth Israel Medical Center, New York, New York
    J Opioid Manag 10:9-20. 2014

Detail Information

Publications19

  1. pmc False sense of safety by daily QTc interval monitoring during methadone IVPCA titration in a patient with chronic pain
    Hector Miranda-Grajales
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY, USA
    J Pain Res 6:375-8. 2013
    ....
  2. ncbi request reprint Safety, tolerability and symptom outcomes associated with L-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I/II study
    Ricardo A Cruciani
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York 10003, USA
    J Pain Symptom Manage 32:551-9. 2006
    ..This study provides the basis for the design of future placebo-controlled studies of l-carnitine supplementation for cancer-related fatigue...
  3. doi request reprint Methadone: to ECG or not to ECG...That is still the question
    Ricardo A Cruciani
    Research Division, Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York 10003, USA
    J Pain Symptom Manage 36:545-52. 2008
    ..Most of the uncertainty is generated by the lack of large controlled studies. This review presents the current data on this issue in an effort to help in the decision-making process until more conclusive data become available...
  4. doi request reprint L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled study
    Ricardo A Cruciani
    Research Division, Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    J Pain Symptom Manage 37:622-31. 2009
    ....
  5. doi request reprint MMTP patients with chronic pain switching to pain management clinics. A problem or an acceptable practice?
    Ricardo A Cruciani
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York 10003, USA
    Pain Med 9:359-64. 2008
    ..Research is needed to evaluate the phenomenology of pain and addiction in this population and the outcomes associated with varied therapeutic strategies...
  6. pmc Using Transcranial Direct Current Stimulation to Treat Depression in HIV-Infected Persons: The Outcomes of a Feasibility Study
    Helena Knotkova
    Research Division, Department of Pain Medicine and Palliative Care, Institute for Non invasive Brain Stimulation, Beth Israel Medical Center New York, NY, USA
    Front Psychiatry 3:59. 2012
    ..Conclusion: Findings support feasibility and clinical potential of tDCS for HIV-MDD patients, and justify larger-sample, sham-controlled trials...
  7. pmc L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial
    Ricardo A Cruciani
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    J Clin Oncol 30:3864-9. 2012
    ..The purpose of this study was to determine the efficacy of L-carnitine supplementation as a treatment for fatigue in patients with cancer...
  8. doi request reprint Transcranial direct current stimulation (tDCS) relieved itching in a patient with chronic neuropathic pain
    Helena Knotkova
    Institute for Non invasive Brain Stimulation, Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY, USA
    Clin J Pain 29:621-2. 2013
    ..Itching is often called the second modality of nociception besides pain, and affects many chronic pain patients...
  9. ncbi request reprint Measurement of QTc in patients receiving chronic methadone therapy
    Ricardo A Cruciani
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York 10003, USA
    J Pain Symptom Manage 29:385-91. 2005
    ..Significant dose response was observed in males on methadone <12 months (rho=0.60, P=0.02). Our study suggests that methadone may prolong the QTc interval in specific subpopulations but poses little risk of serious prolongation...
  10. ncbi request reprint Potential impact of abrupt opioid therapy discontinuation in the management of chronic pain: a pilot study on patient perspective
    Joy Hao
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, New York Department of Medicine, Beth Israel Medical Center, New York, New York
    J Opioid Manag 10:9-20. 2014
    ..This survey highlights the perspective of patients with chronic pain when confronted with the possibility of abrupt opioid discontinuation...
  11. doi request reprint Dose equivalence of immediate-release hydromorphone and once-daily osmotic-controlled extended-release hydromorphone: a randomized, double-blind trial incorporating a measure of assay sensitivity
    Ricardo A Cruciani
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    J Pain 13:379-89. 2012
    ..026) and had greater percent change in the total daily dose of breakthrough medication (P = .037) than the full-dose group, suggesting that switching from IR to ER hydromorphone at the same daily dose provides equivalent analgesia...
  12. doi request reprint Developing patient-centered treatment protocols in brain stimulation: a rationale for combining quantitative and qualitative approaches in persons with HIV
    Mary Rosedale
    New York University College of Nursing, 246 Greene St, NY 10003, USA
    J Am Psychiatr Nurses Assoc 18:166-74. 2012
    ..The authors conclude that the complexity of studying novel treatments in complex and new patient populations requires complex research designs to capture the richness of data that inform translational research...
  13. doi request reprint Medical oncologists' attitudes and practice in cancer pain management: a national survey
    Brenda Breuer
    Beth Israel Medical Center, New York, NY 10003, USA
    J Clin Oncol 29:4769-75. 2011
    ..To evaluate the attitudes, knowledge, and practices of US medical oncologists that are related to management of cancer pain...
  14. ncbi request reprint Pancreatic pain: a mini review
    Ricardo A Cruciani
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
    Pancreatology 8:230-5. 2008
    ..A multidisciplinary approach to manage these complex patients will result in a high yield of success in controlling this and other symptoms. and IAP...
  15. doi request reprint Abnormal heat and pain perception in remitted heroin dependence months after detoxification from methadone-maintenance
    James M Prosser
    The Department of Psychiatry and Behavioral Sciences, Beth Israel Medical Center, Albert Einstein College of Medicine, First Avenue at 16th Street, New York, NY 10003, United States
    Drug Alcohol Depend 95:237-44. 2008
    ..There was no correlation of any measure of drug use history with the heat or pain experience. Abstinent, formerly opioid-dependent patients continue to demonstrate abnormal noxious perception months after detoxification from methadone...
  16. pmc Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocol
    Andrew Rosenblum
    Institute for Treatment and Services Research, National Development and Research Institutes, New York, NY, USA
    J Opioid Manag 8:369-82. 2012
    ..This study convened pain and addiction specialists to develop and pilot a clinical protocol for safe transitioning to Bup/Nx...
  17. pmc Current and future options for the management of phantom-limb pain
    Helena Knotkova
    Department of Pain Medicine and Palliative Care, Research Division, Institute for Non invasive Brain Stimulation, Beth Israel Medical Center, New York, NY, USA
    J Pain Res 5:39-49. 2012
    ..Venues of further development in PLP management include a technological and methodological improvement of existing treatment methods, an implementation of new techniques and products, and a development of new treatment approaches...
  18. doi request reprint Non-invasive transcranial direct current stimulation for the study and treatment of neuropathic pain
    Helena Knotkova
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, Institute for Non Invasive Brain Stimulation of New York, New York, NY, USA
    Methods Mol Biol 617:505-15. 2010
    ..tDCS has been shown to be very safe if utilized within the current protocols. In addition, tDCS has been proven to be easy to apply, portable and not expensive, which further enhances great clinical potential of this technique...
  19. ncbi request reprint Safety and tolerability of high doses of intrathecal fentanyl for the treatment of chronic pain
    Sulane Do Ouro
    Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY, USA
    J Opioid Manag 2:365-8. 2006
    ..Our experience highlights an expanding scope of practice in the use of IT opioids in general and fentanyl specifically and suggests that high-dose fentanyl can be used safely in highly selected patients...